Adtalem Global Education (NYSE:CVSA) Releases FY 2027 Earnings Guidance

Adtalem Global Education (NYSE:CVSA) updated its FY 2027 earnings guidance on Thursday morning. The company provided EPS guidance of 8.900-9.150 for the period, compared to the consensus earnings per share estimate of 8.880. The company issued revenue guidance of $2.1 billion-$2.1 billion, compared to the consensus revenue estimate of $2.1 billion.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Truist Financial upped their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Barrington Research reissued an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a research note on Monday, June 8th. Finally, Wall Street Zen cut Adtalem Global Education from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Adtalem Global Education currently has an average rating of “Moderate Buy” and an average target price of $155.00.

Adtalem Global Education Trading Down 3.0%

CVSA traded down $3.81 during trading hours on Thursday, hitting $125.10. The company’s stock had a trading volume of 547,627 shares, compared to its average volume of 342,955. The firm has a market cap of $4.26 billion, a PE ratio of 16.49, a price-to-earnings-growth ratio of 0.97 and a beta of 0.62. The firm has a 50-day moving average of $124.22. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36. Adtalem Global Education has a 12 month low of $86.97 and a 12 month high of $156.26.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings data on Thursday, August 6th. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, analysts forecast that Adtalem Global Education will post 8.04 earnings per share for the current year.

Insider Buying and Selling at Adtalem Global Education

In other Adtalem Global Education news, CEO Stephen W. Beard sold 15,874 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $131.25, for a total transaction of $2,083,462.50. Following the sale, the chief executive officer directly owned 429,324 shares in the company, valued at $56,348,775. This represents a 3.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert J. Phelan sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $126.21, for a total value of $1,262,100.00. Following the sale, the chief financial officer owned 55,806 shares in the company, valued at approximately $7,043,275.26. This trade represents a 15.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 53,183 shares of company stock worth $6,914,570 in the last 90 days. 2.50% of the stock is currently owned by insiders.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.